Rgc Neuroprotection

RGC neuroprotection

RGC neuroprotection means protecting retinal ganglion cells, the nerve cells in the back of the eye that send visual information to the brain, from damage and death. These cells can be harmed by diseases, injury, or stressors such as high eye pressure, inflammation, or lack of nutrients. Neuroprotection aims to preserve the cells’ health and function through treatments that reduce harmful processes like inflammation, oxidative stress, and programmed cell death. Approaches include drugs that support cell survival, gene or cell therapies that deliver protective molecules, and strategies that boost the eye’s natural repair mechanisms. Some treatments try to block the signals that tell cells to die, while others supply growth factors or new supportive cells. This idea matters because loss of retinal ganglion cells is a major cause of permanent vision loss in conditions such as glaucoma. Lowering eye pressure can slow damage, but neuroprotective strategies could directly save cells and maintain sight even when other measures are not enough. Developing effective neuroprotection faces challenges like getting treatments into the retina, proving long-term safety, and measuring real benefit for vision. Still, progress in this area offers hope for people at risk of losing vision and is a major focus of current research and clinical trials.